Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its fourth-quarter and full-year 2024 financial results, alongside significant progress across its clinical programs and regulatory initiatives. The company continues to drive …
Ocugen Reports 2024 Financial Results and Advances Gene Therapy Programs Read More